Unlocking the potential of cannabis
The world's leading provider of data, intelligence and strategy for the cannabis industry.
The Cannabis World Map
Click each continent to view key statistics on healthcare, market size and more
About UsLearn More
Prohibition Partners unlocks the potential of cannabis through data, intelligence and strategy.
We enable our clients to make better business decisions that deliver transformational growth and disrupt mainstream verticals.
We work with the industry’s most influential stakeholders, some of the world’s best known brands and an unrivalled network of analysts, innovators and advisors.
Our ServicesFind out more
News + InsightsView All
Last Friday, Australian regulator TGA published test results on the most common medical cannabis products sold in Australia. Results, which showed 23% of products had cannabinoid levels which differed from...
Product testing in Australia reveals inconsistencies over cannabinoid potency
Cannabis market set to offer welcome relief during global recession
Prohibition Partners LIVE returns this November with global cannabis conference
European cannabis: waking the sleeping giant. Product Testing in Australia reveals inconsistencies in medical cannabis...
Prohibition Partners LIVE announces November virtual event and Germany’s insured medicinal cannabis sales reach €75...
US Congressional Committee approves the medical cannabis research act and recreational cannabis projects begin to...
Israeli cannabis patient numbers reach 60,000, increasing imports to meet demand & US House vote...